United Patients Group

APRIL 18, 2023

The truth is that it’s impossible to fatally overdose on marijuana alone, as a study in the American Journal of Public Health found no deaths reported due to cannabis use between 1999 and 2007. In fact, there are some patients who prefer not to smoke because of their health conditions or other reasons. Click here to view.

Research and Development 116

Research and Development Indica Treatment Conditions 116

Cannabis Law Report

JULY 12, 2019

Side effects were very prevalent in 79% of all patients taking a refined CBD product, some of which were severe like thrombocytopenia and transaminase elevations in the liver. Review: During an open-label trial of pure CBD with Lennox-Gastaut and Dravet patients, 79% of all patients reported side effects.

Extraction 73

Extraction Pharmaceutical CBD Epilepsy 73

Veriheal

FEBRUARY 28, 2021

The last day of February, the 28th, or the 29th during a leap year is World Rare Disease Day and this day has been designated to help bring awareness to rare diseases as well as the impact they have on patients and their lives. Patients and family members are open to trying anything that might help.

Chronic Pain 52

Chronic Pain Events Therapy Treatment 52

Cannabis Law Report

FEBRUARY 1, 2020

There are now over 1,000 registered patients receiving medical marijuana products by prescription, and this number is projected to surge to 400,000 by 2028. Given single Australians under 35 years old spend about A$849/week total, such high expenditures on marijuana could amount to 25%+ of an epileptic patient’s monthly budget.

Legalization 59

Legalization Research and Development Recreational Access 59

Otherside Farms

MAY 5, 2021

Most medical marijuana patients that use vaporizers aren’t daily smokers but need medical marijuana to reduce the side effects of many diseases that exist to make life more painful and less enjoyable as opposed to not having marijuana in one’s system with a serious, chronic disease.

Vaping 52

Vaping THC Oil Chronic Pain 52

Green Relief

FEBRUARY 20, 2018

Using genetic information to formulate a unique cannabis blend can decrease the “trial and error” phase upon starting cannabis, and provide more consistency in improving patient outcomes. Assessing an individual’s genetics specific to the Endocannabinoid System (including other system pathways that overlap) helps to guide cannabis therapy.

Therapy 40

Therapy Cannabinoids Cannabis Terpenes 40

The Cannigma

APRIL 7, 2022

I was going to live at a place he was buying an Eagle Rock and this guy from Berkeley came in, Don Duncan, who had helped start Berkeley Patients Group and was going to open up LAPCG in Los Angeles. They bought it from your dispensary in Eagle Rock in 2007, and it’s still in their nightstand. MB: I wouldn’t sell carts.

Terpenes 52

Terpenes Wellness and Beauty Cannabis Extraction 52